Niels D. Prins

16.9k citations

124 papers · 9.7k indexed · 4 hit papers · h-index 42

Psychiatry and Mental health top 0.2%
Physiology top 0.5%
Neurology top 0.1%
Pulmonary and Respiratory Medicine top 1%
Neurology top 0.5%

Co-authors: Philip Scheltens Monique M.B. Breteler Peter J. Koudstaal Albert Hofman Tom den Heijer Sarah E. Vermeer Ewoud J. van Dijk Wiesje M. van der Flier
Topics: Dementia and Cognitive Impairment Research (82 papers)Alzheimer's disease research and treatments (44 papers)Neurological Disease Mechanisms and Treatments (18 papers)
Cited by: Neurology Psychiatry and Mental health
Journals: New England Journal of Medicine CirculationSHILAP Revista de lepidopterología
Partner nations: Netherlands United Kingdom United States

In The Last Decade

Niels D. Prins

118 papers receiving 9.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline

2003 1.7k citations Sarah E. Vermeer, Niels D. Prins et al. profile →
White matter hyperintensities, cognitive impairment and dementia: an update

2015 856 citations Niels D. Prins, Philip Scheltens profile →
Cerebral small-vessel disease and decline in information processing speed, executive function and memory

2005 573 citations Niels D. Prins, Ewoud J. van Dijk et al. Brain profile →
Diagnostic Criteria for Vascular Cognitive Disorders

2014 543 citations Niels D. Prins, Philip Scheltens et al. profile →

Peers

Countries citing papers authored by Niels D. Prins

Since Specialization

Citations

This map shows the geographic impact of Niels D. Prins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niels D. Prins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niels D. Prins more than expected).

Fields of papers citing papers by Niels D. Prins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niels D. Prins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niels D. Prins. The network helps show where Niels D. Prins may publish in the future.

Co-authorship network of co-authors of Niels D. Prins

This figure shows the co-authorship network connecting the top 25 collaborators of Niels D. Prins. A scholar is included among the top collaborators of Niels D. Prins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niels D. Prins. Niels D. Prins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Human alveolar macrophage function is impaired in tuberculosis contacts with diabetes 2025 ·EBioMedicine ·Léanie Kleynhans,(unknown),(unknown),(unknown),Alana Keyser,Niels D. Prins,(unknown),(unknown),Virginie Rozot,Martin Kidd,(unknown),Hong Cai,Yufeng Wang,Adam D. Ewing,Stephanus T. Malherbe,Abul Azad,Eusondia Arnett,Blanca I. Restrepo,Larry S. Schlesinger,Katharina Ronacher	0
2	Phase 1/2a Intravenous and Subcutaneous Oligomer-Specific Antibody KHK6640 in Mild to Moderate Alzheimer's Disease 2024 ·The Journal of Prevention of Alzheimer s Disease ·Marc Cantillon,Nancy C. Andreasen,Niels D. Prins	3
3	Effects of Oral ALZ-801/Valiltramiprosate on Plasma Biomarkers, Brain Hippocampal Volume, and Cognition: Results of 2-Year Single-Arm, Open-Label, Phase 2 Trial in APOE4 Carriers with Early Alzheimer’s Disease 2024 ·Drugs ·John A. Hey,Susan Abushakra,Kaj Blennow,Eric M. Reiman,Jakub Hort,Niels D. Prins,Kateřina Sheardová,(unknown),Larry Z. Shen,(unknown),Adem Albayrak,Jijo Paul,Jean F. Schaefer,Aidan Power,Martin Tolar	15
4	Cognitive and Functional Change Over Time in Cognitively Healthy Individuals According to Alzheimer Disease Biomarker-Defined Subgroups 2023 ·Neurology ·(unknown),Heleen M.A. Hendriksen,John Harrison,Everard G.B. Vijverberg,Niels D. Prins,(unknown),(unknown),(unknown),Inge M.W. Verberk,Charlotte E. Teunissen,Elsmarieke van de Giessen,Argonde C. van Harten,Wiesje M. van der Flier,Sietske A.M. Sikkes	18
5	Changes in Brain-Health Related Modifiable Risk Factors in Older Adults After One Year of COVID-19-Restrictions 2022 ·Frontiers in Psychiatry ·(unknown),(unknown),Leonie N.C. Visser,Francesca Mangialasche,Miia Kivipelto,Kay Deckers,Sebastian Köhler,Sietske A.M. Sikkes,Niels D. Prins,Philip Scheltens,Wiesje M. van der Flier,Marissa D. Zwan	4
6	Neuropsychiatric Symptoms as Predictor of Poor Clinical Outcome in Patients With Vascular Cognitive Impairment 2022 ·American Journal of Geriatric Psychiatry ·(unknown),Anna E. Leeuwis,Lieza G. Exalto,Jooske M.F. Boomsma,Niels D. Prins,Jurre H. Verwer,Philip Scheltens,Wiesje M. van der Flier,Geert Jan Biessels	2
7	Neuropathology of FMR1-premutation carriers presenting with dementia and neuropsychiatric symptoms 2021 ·Brain Communications ·Anke A. Dijkstra,(unknown),(unknown),Niels D. Prins,(unknown),Annemieke J.M. Rozemüller,Marianna Bugiani,Wilfred F.A. den Dunnen,Peter K. Todd,Nicolas Charlet‐Berguerand,Rob Willemsen,Renate K. Hukema,Jeroen J.M. Hoozemans	6
8	Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study 2021 ·The Lancet Healthy Longevity ·Inge M.W. Verberk,(unknown),Karlijn A. van den Bosch,Jarith L. Ebenau,Mardou van Leeuwenstijn,Niels D. Prins,Philip Scheltens,Charlotte E. Teunissen,Wiesje M. van der Flier	129
9	Rationale and study design of a randomized, placebo-controlled, double-blind phase 2b trial to evaluate efficacy, safety, and tolerability of an oral glutaminyl cyclase inhibitor varoglutamstat (PQ912) in study participants with MCI and mild AD—VIVIAD 2021 ·Alzheimer s Research & Therapy ·Everard G.B. Vijverberg,(unknown),Asger Reinstrup Bihlet,Kim Henriksen,Frank Weber,Katharina Fuchs,John Harrison,Kerstin Kühn‐Wache,Peter Alexandersen,Niels D. Prins,Philip Scheltens	27
10	Dutch Brain Research Registry for study participant recruitment: Design and first results 2021 ·Alzheimer s & Dementia Translational Research & Clinical Interventions ·Marissa D. Zwan,Wiesje M. van der Flier,(unknown),(unknown),Lisa Vermunt,Roos J. Jutten,Ingrid S. van Maurik,Sietske A.M. Sikkes,Derek Flenniken,(unknown),Michael W. Weiner,Philip Scheltens,Niels D. Prins	33
11	Cerebral amyloid burden is associated with white matter hyperintensity location in specific posterior white matter regions 2019 ·Neurobiology of Aging ·Nick A. Weaver,(unknown),Frederik Barkhof,J. Matthijs Biesbroek,Onno N. Groeneveld,Hugo J. Kuijf,Niels D. Prins,Philip Scheltens,Charlotte E. Teunissen,Wiesje M. van der Flier,Geert Jan Biessels	44
12	Impact of white matter hyperintensity location on depressive symptoms in memory-clinic patients: a lesion–symptom mapping study 2019 ·Journal of Psychiatry and Neuroscience ·Anna E. Leeuwis,Nick A. Weaver,J. Matthijs Biesbroek,Lieza G. Exalto,Hugo J. Kuijf,Astrid M. Hooghiemstra,Niels D. Prins,Philip Scheltens,Frederik Barkhof,Wiesje M. van der Flier,Geert Jan Biessels	11
13	Diagnostic Accuracy of the Frontotemporal Dementia Consensus Criteria in the Late-Onset Frontal Lobe Syndrome 2016 ·Dementia and Geriatric Cognitive Disorders ·Everard G.B. Vijverberg,Annemiek Dols,Welmoed A. Krudop,Anne L. Peters,Cora J. Kerssens,Bart N.M. van Berckel,Mike P. Wattjes,Frederik Barkhof,Flora Gossink,Niels D. Prins,Max L. Stek,Philip Scheltens,Yolande A.L. Pijnenburg	30
14	Identifying bvFTD Within the Wide Spectrum of Late Onset Frontal Lobe Syndrome: A Clinical Approach 2015 ·American Journal of Geriatric Psychiatry ·Welmoed A. Krudop,Cora J. Kerssens,Annemiek Dols,Niels D. Prins,Christiane Möller,Sigfried Schouws,Wiesje M. van der Flier,Philip Scheltens,Sietske A.M. Sikkes,Max L. Stek,Yolande A.L. Pijnenburg	24
15	IS ALZHEIMER’S DISEASE DRUG DEVELOPMENT BROKEN? WHAT MUST BE IMPROVED 2014 ·The Journal of Prevention of Alzheimer s Disease ·(unknown),Jeffrey L. Cummings,Julien Delrieu,Victor Legrand,Niels D. Prins,Bengt Winblad,J. Touchon,M W Weiner,Bruno Vellas	7
16	Building a New Paradigm for the Early Recognition of Behavioral Variant Frontotemporal Dementia: Late Onset Frontal Lobe Syndrome Study 2013 ·American Journal of Geriatric Psychiatry ·Welmoed A. Krudop,Cora J. Kerssens,Annemiek Dols,Niels D. Prins,Christiane Möller,Sigfried Schouws,Frederik Barkhof,Bart N.M. van Berckel,Charlotte E. Teunissen,Wiesje M. van der Flier,Philip Scheltens,Max L. Stek,Yolande A.L. Pijnenburg	34
17	De effectiviteit van vroeg ingezette cognitief-linguïstische- en communicatieve therapie voor afasie na een beroerte: een gerandomiseerde gecontroleerde trial (RATS-2) 2012 ·(unknown),Mieke van de Sandt‐Koenderman,Niels D. Prins,Diederik W.J. Dippel,Peter J. Koudstaal,Evy Visch‐Brink	0
18	Retinal vessel diameters and cerebral small vessel disease: the Rotterdam Scan Study 2005 ·Brain ·M. Kamran Ikram,Frank Jan de Jong,Ewoud J. van Dijk,Niels D. Prins,Albert Hofman,Monique M.B. Breteler,Paulus T.V.M. de Jong	207
19	Alcohol intake in relation to brain magnetic resonance imaging findings in older persons without dementia 2004 ·American Journal of Clinical Nutrition ·Tom den Heijer,Sarah E. Vermeer,Ewoud J. van Dijk,Niels D. Prins,Peter J. Koudstaal,Cornelia M. van Duijn,Albert Hofman,Monique M.B. Breteler	73
20	Cerebral White Matter Lesions and the Risk of Dementia 2004 ·Archives of Neurology ·Niels D. Prins,Ewoud J. van Dijk,Tom den Heijer,Sarah E. Vermeer,Peter J. Koudstaal,Matthijs Oudkerk,Albert Hofman,Monique M.B. Breteler	382

About Niels D. Prins

Niels D. Prins is a scholar working on Psychiatry and Mental health, Neurology and Physiology, having authored 124 papers that have together received 9.7k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (82 papers), Alzheimer's disease research and treatments (44 papers) and Neurological Disease Mechanisms and Treatments (18 papers). The work is most often cited by research in Neurology (2.4k citations), Psychiatry and Mental health (4.1k citations) and Neurology (1.8k citations). Niels D. Prins has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Philip Scheltens, Monique M.B. Breteler, Peter J. Koudstaal, Albert Hofman, Tom den Heijer, Sarah E. Vermeer, Ewoud J. van Dijk, Wiesje M. van der Flier, Frederik Barkhof and Charlotte E. Teunissen. Their work appears in journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact